PIK3CA and neoplasm: Furthermore, the authors demonstrated that a combination of endocrine therapy, CDK4/6 inhibition, and PI3K inhibition is even more effective in vitro as well as in PDX models, in which disease stabilization and tumor regression were observed [81].